Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: RMP who wrote (4112)	1/31/2001 10:55:42 AM
From: Joe	Read Replies (1) \| Respond to of 4140

"Nomograms that are already available to international doctors were presented showing the SUNRISE LTK effect can last longer than a patient's lifetime. In addition, doctors presented data for U.S. nomograms indicating that some of the SUNRISE LTK effect can last 10 years or more." Is our FDA holding LTK back? Why does it work better in Europe than it does in the U.S.? For the same reason that we cannot get many of the safe and effective drugs used in Europe. Maybe a Bush Administration will make a difference, but I am not holding my breath. Joe